Cited by 475Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

Open access

Al-Sarraj, Safa, King, Andrew, Troakes, Claire, Smith, Bradley, Maekawa, Satomi, Bodi, Istvan, Rogelj, Boris, Al-Chalabi, Ammar, Hortobágyi, Tibor, Shaw, Christopher E.·2011·Acta Neuropathologica

DOI 10.1007/s00401-011-0911-2

Open this paper in CoChat — free account

Abstract

Neuronal cytoplasmic inclusions (NCIs) containing phosphorylated TDP-43 (p-TDP-43) are the pathological hallmarks of motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) and FTLD-TDP. The vast majority of NCIs in the brain and spinal cord also label for ubiquitin and p62, however, we have previously reported a subset of TDP-43 proteinopathy patients who have unusual and abundant p62 positive, TDP-43 negative inclusions in the cerebellum and hippocampus. Here we sought to determine whether these cases carry the hexanucleotide repeat expansion in C9orf72. Repeat primer PCR was performed in 36 MND/ALS, FTLD-MND/ALS and FTLD-TDP cases and four controls. Fourteen individuals with the repeat expansion were detected. In all the 14 expansion mutation cases there were abundant globular and star-shaped p62 positive NCIs in the pyramidal cell layer of the hippocampus, the vast majority of which were p-TDP-43 negative. p62 positive NCIs were also abundant in the cerebellar granular and molecular layers in all cases and in Purkinje cells in 12/14 cases but they were only positive for p-TDP-43 in the granular layer of one case. Abundant p62 positive, p-TDP-43 negative neuronal intranuclear inclusions (NIIs) were seen in 12/14 cases in the pyramidal cell layer of the hippocampus and in 6/14 cases in the cerebellar granular layer. This unusual combination of inclusions appears pathognomonic for C9orf72 repeat expansion positive MND/ALS and FTLD-TDP which we believe form a pathologically distinct subset of TDP-43 proteinopathies. Our results suggest that proteins other than TDP-43 are binding p62 and aggregating in response to the mutation which may play a mechanistic role in neurodegeneration.

Integrity signals

Registry

Crossref · 10.1007/s00401-011-0911-2

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Self-citation
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Deng, H.-X., Chen, W., Hong, S.-T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., et al. (2011) · Nature · doi:10.1038/nature10353 · Cited by 1,174
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012

Show all 35 references

Sorted by citations

Items 101–200 of 472

Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
Allen, S. P., Hall, B., Castelli, L. M., Francis, L. I., Woof, R., Siskos, A., Kouloura, E., Gray, E., Thompson, A. G., Talbot, K., et al. (2019) · Brain · doi:10.1093/brain/awy353 · Cited by 102
Patterns of microglial cell activation in frontotemporal lobar degeneration
Lant, S. B., Robinson, A. C., Thompson, J. C., Rollinson, S., Pickering‐Brown, S., Snowden, J. S., Davidson, Y. S., Gerhard, A., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12092 · Cited by 102
Disease Mechanisms ofC9ORF72Repeat ExpansionsPreprint
Gendron, T. F., & Petrucelli, L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024224 · Cited by 106
Pathophysiological insights into ALS with C9ORF72 expansions
Williams, K. L., Fifita, J. A., Vucic, S., Durnall, J. C., Kiernan, M. C., Blair, I. P., & Nicholson, G. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304529 · Cited by 104
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
Webster, C. P., Smith, E. F., Shaw, P. J., & Vos, K. J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00123 · Cited by 109
Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes
Forsberg, K., Graffmo, K. S., Pakkenberg, B., Weber, M., Nielsen, M., Marklund, S. L., Brännström, T., & Andersen, P. M. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319386 · Cited by 99
Label-Free LC–MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis
Collins, M. A., An, J., Hood, B. L., Conrads, T. P., & Bowser, R. P. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00804 · Cited by 101
Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk
Menke, R., Proudfoot, M. J., Wuu, J., Andersen, P. M., Talbot, K., Benatar, M. G., & Turner, M. R. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311945 · Cited by 98
The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases
Cristofani, R., Crippa, V., Vezzoli, G., Rusmini, P., Galbiati, M., Cicardi, M. E., Meroni, M., Ferrari, V., Tedesco, B., Piccolella, M., et al. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0806-9 · Cited by 102
Small heat shock proteins in neurodegenerative diseases
Vendredy, L., Adriaenssens, E., & Timmerman, V. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01101-4 · Cited by 99
Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion
Bieniek, K. F., Murray, M. E., Rutherford, N. J., Castanedes‐Casey, M., DeJesus‐Hernandez, M., Liesinger, A. M., Baker, M., Boylan, K., Rademakers, R., & Dickson, D. W. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1048-7 · Cited by 98
Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration
Gomez-Deza, J., Lee, Y.-B., Troakes, C., Nolan, M., Al-Sarraj, S., Gallo, J.-M., & Shaw, C. E. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0218-y · Cited by 93
Self-citation
The involvement of the cerebellum in amyotrophic lateral sclerosis
Prell, T., & Großkreutz, J. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.812661 · Cited by 96
Widespread structural brain involvement in ALS is not limited to theC9orf72repeat expansion
Westeneng, H., Walhout, R., Straathof, M., Schmidt, R., Hendrikse, J., Veldink, J. H., van den Heuvel, M. P., & van den Berg, L. H. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313959 · Cited by 94
Distinct Clinical Characteristics of C9orf72 Expansion Carriers Compared With GRN, MAPT, and Nonmutation Carriers in a Flanders-Belgian FTLD Cohort
Langenhove, T. V., van der Zee, J., Gijselinck, I., Engelborghs, S., Vandenberghe, R. R., Vandenbulcke, M., Bleecker, J. D., Sieben, A., Versijpt, J. J., Ivanoiu, A., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.181 · Cited by 99
Autophagy receptor defects and ALS-FTLD
Majcher, V., Goode, A., James, V. H., & Layfield, R. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.01.002 · Cited by 101
Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
Budini, M., Buratti, E., Morselli, E., & Criollo, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00170 · Cited by 102
Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD
Lattante, S., de Calbiac, H., Le Ber, I., Brice, A., Ciura, S., & Kabashi, E. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu580 · Cited by 90
Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
Martier, R., Liefhebber, J. M. P., García‐Osta, A., Miniarikova, J., Cuadrado‐Tejedor, M., Espelosin, M., Ursúa, S., Petry, H., van Deventer, S. J. H., Evers, M. M., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.001 · Cited by 91
The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients
Collins, M. A., Riascos, D., Kovalik, T., An, J., Krupa, K., Krupa, K., Hood, B. L., Conrads, T. P., Renton, A. E., Traynor, B. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1045-x · Cited by 90
Cortical Function in Asymptomatic Carriers and Patients WithC9orf72Amyotrophic Lateral Sclerosis
Geevasinga, N., Menon, P., Nicholson, G. A., Ng, K., Howells, J., Kril, J. J., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1872 · Cited by 88
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD
Pang, W., & Hu, F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15255 · Cited by 95
A C9orf72 ALS/FTD Ortholog Acts in Endolysosomal Degradation and Lysosomal Homeostasis
Corrionero, A., & Horvitz, H. R. (2018) · Current Biology · doi:10.1016/j.cub.2018.03.063 · Cited by 91
Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72
Konno, T., Shiga, A., Tsujino, A., Sugai, A., Kato, T., Kanai, K., Yokoseki, A., Eguchi, H., Kuwabara, S., Nishizawa, M., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302272 · Cited by 86
RNA-mediated toxicity in neurodegenerative disease
Belzil, V., Gendron, T. F., & Petrucelli, L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.12.006 · Cited by 90
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder
Zucchi, E., Ticozzi, N., & Mandrioli, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00175 · Cited by 85
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 89
The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties
Chang, Y., Jeng, U., Chiang, Y., Hwang, I., & Chen, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694273 · Cited by 90
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations
van Blitterswijk, M., Baker, M., DeJesus‐Hernandez, M., Ghidoni, R., Benussi, L., Finger, E. C., Hsiung, G. R., Kelley, B. J., Murray, M. E., Rutherford, N. J., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a8250c · Cited by 83
Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS
Geevasinga, N., Menon, P., Ng, K., van den Bos, M. A. J., Byth, K., Kiernan, M. C., & Vucic, S. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1188961 · Cited by 83
Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations
Bede, P., Chipika, R. H., Christidi, F., Hengeveld, J. C., Karavasilis, E., Argyropoulos, G. D., Lope, J., Shing, S. L. H., Velonakis, G., Dupuis, L., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-326854 · Cited by 82
Gene Therapy in Amyotrophic Lateral Sclerosis
Fang, T., Je, G., Pacut, P., Keyhanian, K., Gao, J., & Ghasemi, M. (2022) · Cells · doi:10.3390/cells11132066 · Cited by 88
Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis
Menon, P., Geevasinga, N., van den Bos, M. A. J., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2017) · European Journal of Neurology · doi:10.1111/ene.13295 · Cited by 82
CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis
Dobson‐Stone, C., Hallupp, M., Shahheydari, H., Ragagnin, A., Chatterton, Z., Carew‐Jones, F., Shepherd, C. E., Stefen, H., Parić, E., Fath, T., et al. (2020) · Brain · doi:10.1093/brain/awaa039 · Cited by 86
Self-citation
Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not
Hardy, J., & Rogaeva, E. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.006 · Cited by 83
Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes
Livesey, M. R., Magnani, D., Cleary, E. M., Vasistha, N. A., James, O. T., Selvaraj, B. T., Burr, K., Story, D., Shaw, C. E., Kind, P. C., et al. (2016) · Stem Cells · doi:10.1002/stem.2273 · Cited by 79
Self-citation
Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability
Proudfoot, M. J., Gutowski, N. J., Edbauer, D., Hilton, D. A., Stephens, M., Rankin, J., & Mackenzie, I. R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1245-7 · Cited by 79
Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant
King, A., Al‐Sarraj, S., Troakes, C., Smith, B. N., Maekawa, S., Iovino, M., Spillantini, M. G., & Shaw, C. E. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1050-0 · Cited by 76
Self-citation
The roles of intrinsic disorder-based liquid-liquid phase transitions in the “Dr. Jekyll–Mr. Hyde” behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Uversky, V. N. (2017) · Autophagy · doi:10.1080/15548627.2017.1384889 · Cited by 78
Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration
Maurel, C., Dangoumau, A., Marouillat, S., Brulard, C., Chami, A. A., Hergesheimer, R. C., Corcia, P., Blasco, H., Andres, C. R., & Vourc’h, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0856-0 · Cited by 82
Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Šket, P., Pohleven, J., Kovanda, A., Štalekar, M., Župunski, V., Zalar, M., Plavec, J., & Rogelj, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.012 · Cited by 76
Self-citation
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases
Cristofani, R., Crippa, V., Rusmini, P., Cicardi, M. E., Meroni, M., Licata, N. V., Sala, G., Giorgetti, E., Grunseich, C., Galbiati, M., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1308985 · Cited by 77
TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS
Cunningham, K. M., Maulding, K., Ruan, K., Şentürk, M., Grima, J. C., Sung, H., Zuo, Z., Song, H., Gao, J., Dubey, S. K., et al. (2020) · eLife · doi:10.7554/elife.59419 · Cited by 80
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 76
Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles
Haase, G., & Rabouille, C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00448 · Cited by 78
The selective anatomical vulnerability of ALS: ‘disease-defining’ and ‘disease-defying’ brain regions
Bede, P., Iyer, P. M., Schuster, C., Elamin, M., McLaughlin, R. L., Kenna, K. P., & Hardiman, O. M. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1173702 · Cited by 74
Disruption of ER−mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis
Lau, D. H. W., Hartopp, N., Welsh, N. J., Mueller, S., Glennon, E. B. C., Mórotz, G. M., Annibali, A., Gómez‐Suaga, P., Stoica, R., Paillusson, S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0022-7 · Cited by 77
Insights into the pathogenic mechanisms of chromosome 9 open reading frame 72 (C9orf72) repeat expansions
Todd, T. W., & Petrucelli, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13623 · Cited by 73
Intrinsic Disorder in Proteins with Pathogenic Repeat Expansions
Darling, A. L., & Uversky, V. N. (2017) · Molecules · doi:10.3390/molecules22122027 · Cited by 75
What Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis?
Turner, M. R., & Verstraete, E. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0569-6 · Cited by 71
Impaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 75
C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia
Mizielinska, S., & Isaacs, A. M. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000130 · Cited by 73
Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
Leko, M. B., Župunski, V., Kirincich, J., Smilović, D., Hortobágyi, T., Hof, P. R., & Šimić, G. (2019) · Behavioural Neurology · doi:10.1155/2019/2909168 · Cited by 73
Self-citation
Accumulation of dipeptide repeat proteins predates that of TDP ‐43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene
Baborie, A., Griffiths, T. D., Jaros, E., Perry, R., McKeith, I. G., Burn, D. J., Masuda‐Suzukake, M., Hasegawa, M., Rollinson, S. J., Pickering-Brown, S. M., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12178 · Cited by 73
The Proline/Arginine Dipeptide from Hexanucleotide Repeat Expanded C9ORF72 Inhibits the Proteasome
Gupta, R., Lan, M., Mojsilovic‐Petrovic, J., Choi, W. H., Safren, N., Barmada, S. J., Lee, M. J., & Kalb, R. G. (2017) · eNeuro · doi:10.1523/eneuro.0249-16.2017 · Cited by 74
The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases
Rusmini, P., Cristofani, R., Galbiati, M., Cicardi, M. E., Meroni, M., Ferrari, V., Vezzoli, G., Tedesco, B., Messi, E., Piccolella, M., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00176 · Cited by 71
NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
Gleixner, A. M., Verdone, B. M., Otte, C. G., Anderson, E. N., Ramesh, N., Shapiro, O. R., Gale, J. R., Mauna, J. C., Mann, J. R., Copley, K. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31098-6 · Cited by 71
Association of a Locus in theCAMTA1Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis
Fogh, I., Lin, K., Tiloca, C., Rooney, J. P. K., Gellera, C., Diekstra, F. P., Ratti, A., Shatunov, A., van Es, M. A., Proitsi, P., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1114 · Cited by 68
Self-citation
SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy regulation
Richard, P., Feng, S., Tsai, Y.-L., Li, W., Rinchetti, P., Muhith, U., Irizarry-Cole, J., Stolz, K., Sanz, L. A., Hartono, S. R., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1796292 · Cited by 71
Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
Schmitz, A., Marques, J. P., Oertig, I., Maharjan, N., & Saxena, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.637548 · Cited by 70
Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention
Finegan, E., Chipika, R. H., Shing, S. L. H., Hardiman, O. M., & Bede, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00260 · Cited by 65
An amyloid-like cascade hypothesis for C9orf72 ALS/FTD
Edbauer, D., & Haass, C. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.009 · Cited by 69
C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy
Webster, C. P., Smith, E. F., Grierson, A. J., & Vos, K. J. D. (2016) · Small GTPases · doi:10.1080/21541248.2016.1240495 · Cited by 70
Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB
Kwok, C. T., Morris, A. G., & de Belleroche, J. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.184 · Cited by 67
Structural and functional brain signatures of C9orf72 in motor neuron disease
Agosta, F., Ferraro, P. M., Riva, N., Spinelli, E. G., Domi, T., Carrera, P., Copetti, M., Falzone, Y., Ferrari, M., Lunetta, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.024 · Cited by 65
Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation
Dols‐Icardo, O., García‐Redondo, A., Rojas‐García, R., Borrego‐Hernández, D., Illán‐Gala, I., Muñoz-Blanco, J. L., Rábano, A., Cervera‐Carles, L., Juárez-Rufián, A., Spataro, N., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316820 · Cited by 64
Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Genin, E. C., Abou-Ali, M., & Paquis‐Flucklinger, V. (2023) · Genes · doi:10.3390/genes14111981 · Cited by 64
From nucleation to widespread propagation: A prion-like concept for ALS
Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65
Multiple Kernel Learning Captures a Systems-Level Functional Connectivity Biomarker Signature in Amyotrophic Lateral Sclerosis
Fekete, T., Zach, N., Mujica-Parodi, L. R., & Turner, M. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085190 · Cited by 64
Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment
Kuijpers, M., van Dis, V., Haasdijk, E. D., Harterink, M., Vocking, K., Post, J. A., Scheper, W., Hoogenraad, C. C., & Jaarsma, D. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-24 · Cited by 61
Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
Deng, Z., Sheehan, P., Chen, S., & Yue, Z. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0232-6 · Cited by 62
Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients
Bennett, C. L., Dastidar, S. G., Ling, S., Malik, B., Ashe, T. D., Wadhwa, M., Miller, D. B., Lee, C., Mitchell, M. B., van Es, M. A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1852-9 · Cited by 66
Dysregulation of the Autophagy-Endolysosomal System in Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases
Otomo, A., Pan, L., & Hadano, S. (2012) · Neurology Research International · doi:10.1155/2012/498428 · Cited by 63
Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice
Hadano, S., Mitsui, S., Pan, L., Otomo, A., Kubo, M., Sato, K., Ono, S., Onodera, W., Abe, K., Chen, X.-P., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw180 · Cited by 62
Intrinsic disorder in proteins involved in amyotrophic lateral sclerosis
Santamaria, N., Alhothali, M., Alfonso, M. B. H., Breydo, L., & Uversky, V. N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2416-6 · Cited by 60
Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Mihevc, S. P., Darovic, S., Kovanda, A., Česnik, A. B., Župunski, V., & Rogelj, B. (2016) · Brain · doi:10.1093/brain/aww197 · Cited by 62
Self-citation
p62/SQSTM1 Differentially Removes the Toxic Mutant Androgen Receptor via Autophagy and Inclusion Formation in a Spinal and Bulbar Muscular Atrophy Mouse Model
Doi, H., Adachi, H., Katsuno, M., Minamiyama, M., Matsumoto, S., Kondo, N., Miyazaki, Y., Iida, M., Tohnai, G., Qiang, Q., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3021-12.2013 · Cited by 58
Implications of Selective Autophagy Dysfunction for ALS Pathology
Vicencio, E., Beltrán, S., Labrador, L., Manque, P., Nassif, M., & Woehlbier, U. (2020) · Cells · doi:10.3390/cells9020381 · Cited by 60
Amyotrophic lateral sclerosis: an update on recent genetic insights
Iguchi, Y., Katsuno, M., Ikenaka, K., Ishigaki, S., & Sobue, G. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7112-y · Cited by 56
Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study
Schönecker, S., Neuhofer, C. M., Otto, M., Ludolph, A. C., Kassubek, J., Landwehrmeyer, G. B., Anderl‐Straub, S., Semler, E., Diehl‐Schmid, J., Prix, C., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00045 · Cited by 56
Nuclear RNA foci fromC9ORF72expansion mutation form paraspeckle-like bodies
Česnik, A. B., Darovic, S., Mihevc, S. P., Štalekar, M., Malnar, M., Motaln, H., Lee, Y., Mazej, J., Pohleven, J., Grosch, M., et al. (2019) · Journal of Cell Science · doi:10.1242/jcs.224303 · Cited by 61
Self-citation
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
Cooper‐Knock, J., Kirby, J., Highley, J. R., & Shaw, P. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0342-1 · Cited by 58
Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study
Al‐Sarraj, S., King, A., Cleveland, M. S., Pradat, P., Corse, A. M., Rothstein, J. D., Leigh, P., Abila, B., Bates, S., Würthner, J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0165-z · Cited by 57
Self-citation
C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature
Bourinaris, T., & Houlden, H. (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12677 · Cited by 58
Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD
Yuva-Aydemir, Y., Almeida, S., Krishnan, G., Gendron, T. F., & Gao, F. (2019) · Nature Communications · doi:10.1038/s41467-019-13477-8 · Cited by 55
C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism
O'Dowd, S., Curtin, D., Waite, A. J., Roberts, K., Pender, N., Reid, V., O'Connell, M., Williams, N. M., Morris, H. R., Traynor, B. J., et al. (2012) · Movement Disorders · doi:10.1002/mds.25022 · Cited by 52
MRI Clustering Reveals Three ALS Subtypes With Unique Neurodegeneration Patterns
Tan, H. H. G., Westeneng, H., Nitert, A. D., van Veenhuijzen, K., Meier, J. M., van der Burgh, H. K., van Zandvoort, M. J. E., van Es, M. A., Veldink, J. H., & van den Berg, L. H. (2022) · Annals of Neurology · doi:10.1002/ana.26488 · Cited by 52
Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly
Sharkey, L. M., Safren, N., Pithadia, A. S., Gerson, J. E., Dulchavsky, M. E., Fischer, S., Patel, R., Lantis, G., Ashraf, N., Kim, J. H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810522115 · Cited by 53
Computational insights into mechanism of AIM4-mediated inhibition of aggregation of TDP-43 protein implicated in ALS and evidence for in vitro inhibition of liquid-liquid phase separation (LLPS) of TDP-432C-A315T by AIM4
Girdhar, A., Bharathi, V., Tiwari, V. R., Abhishek, S., Deeksha, W., Mahawar, U., Raju, G., Singh, S. K., Prabusankar, G., Rajakumara, E., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.032 · Cited by 52
UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia
Fecto, F., & Siddique, T. (2011) · Muscle & Nerve · doi:10.1002/mus.23278 · Cited by 53
Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia
Stepto, A., Gallo, J., Shaw, C. E., & Hirth, F. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1235-1 · Cited by 53
Self-citation
The Emerging Roles of MicroRNAs in the Pathogenesis of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis (FTD-ALS) Spectrum Disorders
Gascon, E., & Gao, F. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2013.876021 · Cited by 54
Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review
Pan, X., & Chen, X. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-8 · Cited by 57
Neuropathology of RAN translation proteins in fragile X-associated tremor/ataxia syndrome
Krans, A., Skariah, G., Zhang, Y., Bayly, B., & Todd, P. K. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0782-7 · Cited by 51
Quantitative patterns of motor cortex proteinopathy across ALS genotypes
Nolan, M., Scott, C., Pallebage‐Gamarallage, M. M., Lunn, D., Carpenter, K., McDonough, E., Meyer, D. E., Kaanumalle, S., Santamaría-Pang, A., Turner, M. R., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00961-2 · Cited by 55
Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development
Hargus, G., Ehrlich, M., Hallmann, A.-L., & Kuhlmann, T. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1222-6 · Cited by 54
Clinico-Pathological Correlations of the Most Common Neurodegenerative Dementias
Taipa, R. J. F., Pinho, J., & Pires, M. M. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00068 · Cited by 54
Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS
Vucic, S., Pavey, N., Haidar, M., Turner, B. J., & Kiernan, M. C. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136039 · Cited by 52
Role of Autophagy Pathway in Parkinson’s Disease and Related Genetic Neurological Disorders
Themistokleous, C., Bagnoli, E., Parulekar, R., & Muqit, M. M. K. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168144 · Cited by 51
Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Vatovec, S., Kovanda, A., & Rogelj, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.015 · Cited by 53
Self-citation

Authors: Al-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., Rogelj, B., Al-Chalabi, A., Hortobágyi, T., & Shaw, C. E.
Affiliations: King's College London (GB)
Corresponding author: King, Andrew
ORCID: King, Andrew
Troakes, Claire
Smith, Bradley
Rogelj, Boris
Hortobágyi, Tibor
Shaw, Christopher E.
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2011-11-19
Volume: 122
Issue: 6
Pages: 691-702
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-011-0911-2
OpenAlex: W2066002405
Cited by: 475
References: 35
Citations by year: 2026: 9 · 2025: 9 · 2024: 22 · 2023: 24 · 2022: 23 · 2021: 23 · 2020: 40 · 2019: 27 · 2018: 24 · 2017: 39 · 2016: 38 · 2015: 41 · 2014: 42 · 2013: 63 · 2012: 45
FWCI: 31.22
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
Research Portal (King's College London) (submittedVersion)
Funders: Wellcome Trust (089701)
Medical Research Council (MC_G1000733)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: p62, TDP-43, C9orf72, hexanucleotide repeat expansion, amyotrophic lateral sclerosis, motor neuron disease, frontotemporal lobar degeneration, FTLD-TDP, neuronal cytoplasmic inclusions, neuronal intranuclear inclusions, cerebellum, hippocampus, Purkinje cells, neurodegeneration, protein aggregation
MeSH terms: Sequestosome-1 Protein, C9orf72 Protein, Adult, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Inclusion Bodies, Cerebellum, DNA, DNA-Binding Proteins, Female, Hippocampus, Humans, Male, Middle Aged, Mutation, Neurons, Proteins, Purkinje Cells, Case-Control Studies, Pyramidal Cells, DNA Repeat Expansion, Intranuclear Inclusion Bodies, Adaptor Proteins, Signal Transducing, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks